T1	Eq-Comparison 178 185	Current
E1	Eq-Comparison:T1 Temporal-Period:T2
T2	Eq-Temporal-Period 178 185	Current
A1	Eq-Temporal-Period-Value T2 present
T3	Eq-Comparison 334 341	Current
E2	Eq-Comparison:T3 Temporal-Period:T4
T4	Eq-Temporal-Period 334 341	Current
A2	Eq-Temporal-Period-Value T4 present
T5	Eq-Comparison 1131 1138	current
E3	Eq-Comparison:T5 Temporal-Period:T6
T6	Eq-Temporal-Period 1131 1138	current
A3	Eq-Temporal-Period-Value T6 present
T7	Eq-Comparison 1142 1150	previous
E4	Eq-Comparison:T7 Temporal-Period:T8
T8	Eq-Temporal-Period 1142 1150	previous
A4	Eq-Temporal-Period-Value T8 past
T9	Eq-Comparison 1180 1187	current
E5	Eq-Comparison:T9 Temporal-Period:T10
T10	Eq-Temporal-Period 1180 1187	current
A5	Eq-Temporal-Period-Value T10 present
T11	Eq-Comparison 1191 1199	previous
E6	Eq-Comparison:T11 Temporal-Period:T12
T12	Eq-Temporal-Period 1191 1199	previous
A6	Eq-Temporal-Period-Value T12 past
T13	Eq-Comparison 109 118	within 3y
E7	Eq-Comparison:T13 Operator:T24 Temporal-Unit:T26 Value:T25
T15	Eq-Comparison 495 503	2 months
E8	Eq-Comparison:T15 Value:T16 Temporal-Unit:T61
T17	Life-Stage-And-Gender 25 31	Female
A9	Life-Stage-And-Gender-Type T17 female
T18	Condition 58 71	endometriosis
E9	Condition:T18 Name:T19
T19	Condition-Name 58 71	endometriosis
T20	Procedure 37 47	surgically
E10	Procedure:T20 Name:T21
T21	Procedure-Name 37 47	surgically
R1	Found-By Arg1:E9 Arg2:E10	
T22	Procedure 87 98	laparoscopy
E11	Procedure:T22 Name:T23 Temporality:E7
T23	Procedure-Name 87 98	laparoscopy
R2	Found-By Arg1:E9 Arg2:E11	
T24	Eq-Operator 109 115	within
A10	Eq-Operator-Value T24 LTEQ
T25	Eq-Value 116 117	3
T26	Eq-Temporal-Unit 117 118	y
A11	Eq-Temporal-Unit-Value T26 year
T14	Temporal-Connection 119 127	prior to
E12	Temporal-Connection:T14 Arg:E7 Arg2:E13
A7	Temporal-Connection-Type-Value E12 before
T27	Study 128 133	study
E13	Study:T27 
T28	Age 148 151	Age
E14	Age:T28 Eq-Comparison:E15
T29	Eq-Comparison 152 172	15 years to 40 years
E15	Eq-Comparison:T29 Value:T30 Temporal-Unit:T31 Operator:T32 Value2:T33 Temporal-Unit2:T34
T30	Eq-Value 152 154	15
T31	Eq-Temporal-Unit 155 160	years
A12	Eq-Temporal-Unit-Value T31 year
T32	Eq-Operator 161 163	to
A13	Eq-Operator-Value T32 BETWEEN
T33	Eq-Value 164 166	40
T34	Eq-Temporal-Unit 167 172	years
A14	Eq-Temporal-Unit-Value T34 year
T35	Eq-Comparison 190 200	≥ 2 months
E16	Eq-Comparison:T35 Operator:T36 Value:T37 Temporal-Unit:T38
T36	Eq-Operator 190 191	≥
A15	Eq-Operator-Value T36 GTEQ
T37	Eq-Value 192 193	2
T38	Eq-Temporal-Unit 194 200	months
A16	Eq-Temporal-Unit-Value T38 month
T39	Procedure 213 229	hormonal therapy
E17	Procedure:T39 Name:T40 Temporality:E1 Duration:E16
T40	Procedure-Name 213 229	hormonal therapy
T41	Procedure 247 266	oral contraceptives
E18	Procedure:T41 Name:T42
T42	Procedure-Name 247 266	oral contraceptives
T43	Modifier 238 246	combined
E19	Modifier:T43 Modifies:T42
R3	Example-Of Arg1:E18 Arg2:E17	
T44	Drug 268 289	norethindrone acetate
E20	Drug:T44 Name:T45
T45	Drug-Name 268 289	norethindrone acetate
R4	Example-Of Arg1:E20 Arg2:E17	
T46	Procedure 294 328	levonorgestrel intrauterine device
E21	Procedure:T46 Name:T47
T47	Procedure-Name 294 328	levonorgestrel intrauterine device
R5	Example-Of Arg1:E21 Arg2:E17	
T48	Or 291 293	or
E22	Or:T48 Arg:E20 Arg2:E21
T49	Condition 349 353	pain
E23	Condition:T49 Name:T50 Temporality:E2 Duration:E27
T50	Condition-Name 349 353	pain
T51	Modifier 342 348	pelvic
E24	Modifier:T51 Modifies:T50
T52	Observation 349 353	pain
E25	Observation:T52 Eq-Comparison:E26
T53	Eq-Comparison 361 364	≥ 3
E26	Eq-Comparison:T53 Operator:T54 Value:T55
T54	Eq-Operator 361 362	≥
A17	Eq-Operator-Value T54 GTEQ
T55	Eq-Value 363 364	3
T56	Eq-Comparison 470 485	≥ 14 days/month
E27	Eq-Comparison:T56 Operator:T57 Value:T58 Temporal-Unit:T59 Per:T60
T57	Eq-Operator 470 471	≥
A18	Eq-Operator-Value T57 GTEQ
T58	Eq-Value 472 474	14
T59	Eq-Temporal-Unit 475 479	days
A19	Eq-Temporal-Unit-Value T59 day
T60	Eq-Temporal-Unit 480 485	month
A20	Eq-Temporal-Unit-Value T60 month
T16	Eq-Value 495 496	2
T61	Eq-Temporal-Unit 497 503	months
A8	Eq-Temporal-Unit-Value T61 month
T62	Temporal-Connection 486 490	over
E28	Temporal-Connection:T62 Arg:E23 Arg2:E8
A21	Temporal-Connection-Type-Value E28 during
T63	Study 513 518	study
E29	Study:T63 
T64	Temporal-Connection 504 512	prior to
E30	Temporal-Connection:T64 Arg:E8 Arg2:E29
A22	Temporal-Connection-Type-Value E30 before
T65	Assertion 535 546	Willingness
E31	Assertion:T65 Asserted:E32
A23	Assertion-Type-Value E31 hypothetical
T66	Encounter 562 567	visit
E32	Encounter:T66 
T67	Condition 619 627	menarche
E33	Condition:T67 Name:T68
T68	Condition-Name 619 627	menarche
T69	Condition 636 645	menopause
E34	Condition:T69 Name:T71
T70	Temporal-Connection 615 618	Pre
E35	Temporal-Connection:T70 Arg:E33
A24	Temporal-Connection-Type-Value E35 before
T71	Condition-Name 636 645	menopause
T72	Temporal-Connection 631 635	post
E36	Temporal-Connection:T72 Arg:E34
A25	Temporal-Connection-Type-Value E36 after
T73	Or 628 630	or
E37	Or:T73 Arg:E33 Arg2:E34
T74	Drug 672 683	cabergoline
E38	Drug:T74 Name:T75
T75	Drug-Name 672 683	cabergoline
T76	Contraindication 651 668	Contraindications
E39	Contraindication:T76 Contraindicates:E38
T77	Condition 691 713	cardiac valve disorder
E40	Condition:T77 Name:T78
T78	Condition-Name 691 713	cardiac valve disorder
R6	Example-Of Arg1:E40 Arg2:E39	
T79	Condition 764 772	disorder
E41	Condition:T79 Name:T80
T80	Condition-Name 764 772	disorder
T81	Modifier 715 724	pulmonary
E42	Modifier:T81 Modifies:T80
T82	Modifier 726 737	pericardial
E43	Modifier:T82 Modifies:T80
T83	Modifier 739 763	retroperitoneal fibrotic
E44	Modifier:T83 Modifies:T80
R7	Example-Of Arg1:E41 Arg2:E39	
T84	Condition 774 790	hypersensitivity
E45	Condition:T84 Name:T85
T85	Condition-Name 774 790	hypersensitivity
T86	Modifier 794 811	ergot derivatives
E46	Modifier:T86 Modifies:T85
R8	Example-Of Arg1:E45 Arg2:E39	
T87	Condition 826 838	hypertension
E47	Condition:T87 Name:T88
T88	Condition-Name 826 838	hypertension
T89	Modifier 813 825	uncontrolled
E48	Modifier:T89 Modifies:T88
R9	Example-Of Arg1:E47 Arg2:E39	
T90	Condition 884 891	illness
E49	Condition:T90 Name:T91 Severity:T95
T91	Condition-Name 884 891	illness
T92	Modifier 857 863	mental
E50	Modifier:T92 Modifies:T91
T93	Modifier 875 883	systemic
E51	Modifier:T93 Modifies:T91
T94	Or 864 866	or
E52	Or:T94 Arg:E50 Arg2:E51
T95	Severity 845 856	Significant
A26	Severity-Value T95 severe
T96	Procedure 912 927	pain assessment
E53	Procedure:T96 Name:T97 Stability:T98
T97	Procedure-Name 912 927	pain assessment
T98	Stability 903 911	confound
A27	Stability-Value T98 change
T99	Assertion 897 902	might
E54	Assertion:T99 Asserted:T98
A28	Assertion-Type-Value E54 hypothetical
R10	Caused-By Arg1:T98 Arg2:E49	
T100	Study 959 964	study
E55	Study:T100 
T101	Assertion 935 945	ability to
E56	Assertion:T101 Asserted:E55
A29	Assertion-Type-Value E56 hypothetical
T102	Or 928 930	or
E57	Or:T102 Arg:E53 Arg2:E56
T103	Condition 970 978	Pregnant
E58	Condition:T103 Name:T104
T104	Condition-Name 970 978	Pregnant
T105	Condition 980 993	breastfeeding
E59	Condition:T105 Name:T106
T106	Condition-Name 980 993	breastfeeding
T107	Condition 1017 1025	pregnant
E60	Condition:T107 Name:T108 Temporality:E63
T108	Condition-Name 1017 1025	pregnant
T109	Assertion 998 1016	planning to become
E61	Assertion:T109 Asserted:E60
A30	Assertion-Type-Value E61 intention
T110	Or 995 997	or
E62	Or:T110 Arg:E59 Arg2:E61
T111	Eq-Comparison 1033 1046	next 6 months
E63	Eq-Comparison:T111 Temporal-Period:T112 Value:T113 Temporal-Unit:T114
T112	Eq-Temporal-Period 1033 1037	next
A31	Eq-Temporal-Period-Value T112 future
T113	Eq-Value 1038 1039	6
T114	Eq-Temporal-Unit 1040 1046	months
A32	Eq-Temporal-Unit-Value T114 month
T115	Condition 1123 1129	cancer
E64	Condition:T115 Name:T116 Temporality:E3 Temporality2:E4
T116	Condition-Name 1123 1129	cancer
T117	Modifier 1116 1122	Breast
E65	Modifier:T117 Modifies:T116
T118	Or 1139 1141	or
E66	Or:T118 Arg:E3 Arg2:E4
T119	Condition 1156 1178	Thromboembolic disease
E67	Condition:T119 Name:T120 Temporality:E5 Temporality2:E6
T120	Condition-Name 1156 1178	Thromboembolic disease
T121	Or 1188 1190	or
E68	Or:T121 Arg:E5 Arg2:E6
T122	Drug 1218 1223	drugs
E69	Drug:T122 
T123	Drug 1236 1244	dopamine
E70	Drug:T123 Name:T124 Stability:T126
T124	Drug-Name 1236 1244	dopamine
T125	Other 1212 1217	other
E71	Other:T125 Is-Other:E69
T126	Stability 1229 1235	affect
A33	Stability-Value T126 change
R11	Caused-By Arg1:T126 Arg2:E69	
T127	Drug 1252 1266	phenothiazines
E72	Drug:T127 Name:T128
T128	Drug-Name 1252 1266	phenothiazines
R12	Example-Of Arg1:E72 Arg2:E69	
T129	Drug 1268 1282	metoclopramide
E73	Drug:T129 Name:T130
T130	Drug-Name 1268 1282	metoclopramide
R13	Example-Of Arg1:E73 Arg2:E69	
T131	Drug 1284 1298	butyrophenones
E74	Drug:T131 Name:T132
T132	Drug-Name 1284 1298	butyrophenones
R14	Example-Of Arg1:E74 Arg2:E69	
T133	Modifier 867 874	chronic
E75	Modifier:T133 Modifies:T91
T134	Assertion 1229 1235	affect
E76	Assertion:T134 Asserted:T126
A34	Assertion-Type-Value E76 hypothetical
